An existing rabies treatment, known as KEDRAB, was found by researchers to be safe and effective for patients age 17 and under.
Published in Human Vaccines & Immunotherapeutics on February 9, 2021, these researchers report the first and only pediatric trial of any human rabies immunoglobulin (HRIG) currently available in the USA.
According to the U.S. CDC, someone is treated for possible exposure to rabies every 10 minutes, and once clinical symptoms appear, rabies is virtually 100% fatal, said these researchers.
Read More
